Cédric Draulans

1.2k total citations · 1 hit paper
28 papers, 730 citations indexed

About

Cédric Draulans is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Surgery. According to data from OpenAlex, Cédric Draulans has authored 28 papers receiving a total of 730 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pulmonary and Respiratory Medicine, 15 papers in Radiation and 4 papers in Surgery. Recurrent topics in Cédric Draulans's work include Prostate Cancer Diagnosis and Treatment (23 papers), Prostate Cancer Treatment and Research (19 papers) and Advanced Radiotherapy Techniques (15 papers). Cédric Draulans is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (23 papers), Prostate Cancer Treatment and Research (19 papers) and Advanced Radiotherapy Techniques (15 papers). Cédric Draulans collaborates with scholars based in Belgium, Netherlands and Slovenia. Cédric Draulans's co-authors include Karin Haustermans, Sofie Isebaert, Uulke A. van der Heide, Robert Jan Smeenk, Linda G.W. Kerkmeijer, Floris J. Pos, Martina Kunze-Busch, Evelyn M. Monninkhof, V. Groen and Jochem van der Voort van Zijp and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Urology and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Cédric Draulans

25 papers receiving 728 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Focal Boost to the Intraprostatic Tumor in External Beam Radiotherapy for Patients With Localized Prostate Cancer: Results From the FLAME Randomized Phase III Trial

2021 299 citations Linda G.W. Kerkmeijer, V. Groen et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Cédric Draulans

Since Specialization

Citations

This map shows the geographic impact of Cédric Draulans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cédric Draulans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cédric Draulans more than expected).

Fields of papers citing papers by Cédric Draulans

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cédric Draulans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cédric Draulans. The network helps show where Cédric Draulans may publish in the future.

Co-authorship network of co-authors of Cédric Draulans

This figure shows the co-authorship network connecting the top 25 collaborators of Cédric Draulans. A scholar is included among the top collaborators of Cédric Draulans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cédric Draulans. Cédric Draulans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Stereotactic arrhythmia radioablation in patients with refractory ventricular tachycardia: a systematic review and meta-analysis 2025 ·Heart ·Eveline R. Goethals, (unknown), Robin De Roover, Kenneth Poels, Cédric Draulans, Eef Dries, Tom Depuydt, Patrick Berkovic, Gábor Vörös, Piet Claus, Steven Dymarkowski, J. Bogaert, Joris Ector, Bert Vandenberk	0
2	Focal Boost to the Intraprostatic Tumor in External Beam Radiotherapy for Patients With Localized Prostate Cancer: 10-Year Outcomes of the FLAME Trial 2025 ·Journal of Clinical Oncology ·(unknown), Cédric Draulans, Floris J. Pos, Linda G.W. Kerkmeijer, Evelyn M. Monninkhof, Robert Jan Smeenk, Martina Kunze-Busch, Hans C.J. de Boer, (unknown), Karin Haustermans, Uulke A. van der Heide	1
3	3462 Elective irradiation of the para-aortic lymph nodes in pN1 prostate cancer: interim results of the multicentric, non-randomized phase 2 PART Trial 2025 ·Radiotherapy and Oncology ·(unknown), Steven Joniau, J. M. Hartog, Cédric Draulans, Laura Van den Bergh, (unknown), Valérie Fonteyne, Christof Vulsteke, Filip Ameye, (unknown), (unknown), (unknown), Gert De Meerleer	0
4	3396: Focal boost SBRT in men with intermediate- and high-risk PCa: 5-year results of the hypo-FLAME trial 2024 ·Radiotherapy and Oncology ·Cédric Draulans, Karin Haustermans, Floris J. Pos, Uulke A. van der Heide, (unknown), (unknown), Hans C.J. de Boer, Robert Jan Smeenk, Martina Kunze-Busch, Evelyn M. Monninkhof, Robin De Roover, Sofie Isebaert, Linda G.W. Kerkmeijer	1
5	Intra-prostatic recurrences after radiotherapy with focal boost: Location and dose mapping in the FLAME trial 2024 ·Radiotherapy and Oncology ·(unknown), Floris J. Pos, Ivo G. Schoots, Walther Vogel, Linda G.W. Kerkmeijer, Evelyn M. Monninkhof, Johannes C.J. de Boer, Jochem R.N. van der Voort van Zyp, (unknown), (unknown), Cédric Draulans, (unknown), Petra J. van Houdt, Uulke A. van der Heide	4
6	Stereotactic body radiotherapy with a focal boost to the intraprostatic tumor for intermediate and high risk prostate cancer: 5-year efficacy and toxicity in the hypo-FLAME trial 2024 ·Radiotherapy and Oncology ·Cédric Draulans, Karin Haustermans, Floris J. Pos, Uulke A. van der Heide, (unknown), Jochem van der Voort van Zyp, Hans de Boer, Robert Jan Smeenk, Martina Kunze-Busch, Evelyn M. Monninkhof, Robin De Roover, Sofie Isebaert, Linda G.W. Kerkmeijer	16
7	Risk Modeling for Individualization of the FLAME Focal Boost Approach in External Beam Radiation Therapy for Patients With Localized Prostate Cancer 2023 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown), V. Groen, Floris J. Pos, Evelyn M. Monninkhof, Sjoerd G. Elias, Karin Haustermans, Robert Jan Smeenk, Jochem van der Voort van Zyp, Cédric Draulans, Sofie Isebaert, Petra J. van Houdt, Linda G.W. Kerkmeijer, Uulke A. van der Heide	8
8	From once-weekly to semi-weekly whole prostate gland stereotactic radiotherapy with focal boosting: Primary endpoint analysis of the multicenter phase II hypo-FLAME 2.0 trial 2023 ·Radiotherapy and Oncology ·(unknown), Cédric Draulans, Floris J. Pos, Sofie Isebaert, Robin De Roover, Uulke A. van der Heide, Robert Jan Smeenk, Martina Kunze-Busch, Jochem van der Voort van Zyp, Hans de Boer, Linda G.W. Kerkmeijer, Karin Haustermans	21
9	Focal Boost to the Intraprostatic Tumor in External Beam Radiotherapy for Patients With Localized Prostate Cancer: Results From the FLAME Randomized Phase III Trial breakdown → 2021 ·Journal of Clinical Oncology ·Linda G.W. Kerkmeijer, V. Groen, Floris J. Pos, Karin Haustermans, Evelyn M. Monninkhof, Robert Jan Smeenk, Martina Kunze-Busch, Johannes C.J. de Boer, Jochem van der Voort van Zijp, Marco van Vulpen, Cédric Draulans, Laura Van den Bergh, Sofie Isebaert, Uulke A. van der Heide	299
10	Anorectal dose–effect relations for late gastrointestinal toxicity following external beam radiotherapy for prostate cancer in the FLAME trial 2021 ·Radiotherapy and Oncology ·V. Groen, Nicolaas P. A. Zuithoff, (unknown), Evelyn M. Monninkhof, Martina Kunze-Busch, Hans C.J. de Boer, Jochem van der Voort van Zyp, Floris J. Pos, Robert Jan Smeenk, Karin Haustermans, Sofie Isebaert, Cédric Draulans, Tom Depuydt, Helena M. Verkooijen, Uulke A. van der Heide, Linda G.W. Kerkmeijer	16
11	Urethral and bladder dose–effect relations for late genitourinary toxicity following external beam radiotherapy for prostate cancer in the FLAME trial 2021 ·Radiotherapy and Oncology ·V. Groen, (unknown), Nicolaas P. A. Zuithoff, Evelyn M. Monninkhof, Martina Kunze-Busch, Johannes C.J. de Boer, Jochem van der Voort van Zijp, Floris J. Pos, Robert Jan Smeenk, Karin Haustermans, Sofie Isebaert, Cédric Draulans, Tom Depuydt, Helena M. Verkooijen, Uulke A. van der Heide, Linda G.W. Kerkmeijer	36
12	Patterns of Failure Following External Beam Radiotherapy With or Without an Additional Focal Boost in the Randomized Controlled FLAME Trial for Localized Prostate Cancer 2021 ·European Urology ·V. Groen, Karin Haustermans, Floris J. Pos, Cédric Draulans, Sofie Isebaert, Evelyn M. Monninkhof, Robert Jan Smeenk, Martina Kunze-Busch, Johannes C.J. de Boer, Jochem van der Voort van Zijp, Linda G.W. Kerkmeijer, Uulke A. van der Heide	38
13	A fatal wound complication following sequential anti-angiogenesis, immune checkpoint inhibition and ultra-hypofractionated radiotherapy 2021 ·Clinical Journal of Gastroenterology ·(unknown), Cédric Draulans, (unknown), Eric Van Cutsem, (unknown), Gert De Meerleer, Sabine Tejpar, Jeroen Dekervel, Karin Haustermans	0
14	Primary endpoint analysis of the multicentre phase II hypo-FLAME trial for intermediate and high risk prostate cancer 2020 ·Radiotherapy and Oncology ·Cédric Draulans, Uulke A. van der Heide, Karin Haustermans, Floris J. Pos, Jochem van der Voort van Zyp, Hans de Boer, V. Groen, Evelyn M. Monninkhof, Robert Jan Smeenk, Martina Kunze-Busch, Robin De Roover, Tom Depuydt, Sofie Isebaert, Linda G.W. Kerkmeijer	115
15	Knowledge-Based Assessment of Focal Dose Escalation Treatment Plans in Prostate Cancer 2020 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown), Tomas Janssen, (unknown), Iris Walraven, Floris J. Pos, Peter de Ruiter, A.N.T.J. Kotte, Evelyn M. Monninkhof, Linda G.W. Kerkmeijer, Cédric Draulans, Robin De Roover, Karin Haustermans, Martina Kunze-Busch, Robert Jan Smeenk, Uulke A. van der Heide	16
16	Optimal 68Ga-PSMA and 18F-PSMA PET window levelling for gross tumour volume delineation in primary prostate cancer 2020 ·European Journal of Nuclear Medicine and Molecular Imaging ·Cédric Draulans, Robin De Roover, Uulke A. van der Heide, Linda G.W. Kerkmeijer, Robert Jan Smeenk, Floris J. Pos, Wouter V. Vogel, James Nagarajah, Marcel J. R. Janssen, Sofie Isebaert, Frederik Maes, Cindy Mai, Raymond Oyen, Steven Joniau, Martina Kunze-Busch, Karolien Goffin, Karin Haustermans	28
17	Variation in adjuvant and early salvage radiotherapy after robot-assisted radical prostatectomy for prostate cancer: a population-based cohort study 2020 ·Acta Oncologica ·Cédric Draulans, Nancy Van Damme, Sofie Isebaert, Wouter Everaerts, Geert Silversmit, Steven Joniau, Gert De Meerleer, E. Van Eycken, Karin Haustermans, Filip Ameye, Thierry Roumeguère, (unknown), Thierry Quackels, Ben Van Cleynenbreugel	1
18	Impact of Magnetic Resonance Imaging on Prostate Cancer Staging and European Association of Urology Risk Classification 2019 ·Urology ·Cédric Draulans, Wouter Everaerts, Sofie Isebaert, Thomas Gevaert, Raymond Oyen, Steven Joniau, Evelyne Lerut, Liesbeth De Wever, Birgit Weynand, (unknown), Gert De Meerleer, Karin Haustermans	22
19	Stereotactic body radiation therapy with optional focal lesion ablative microboost in prostate cancer: Topical review and multicenter consensus 2019 ·Radiotherapy and Oncology ·Cédric Draulans, Robin De Roover, Uulke A. van der Heide, Karin Haustermans, Floris J. Pos, Robert Jan Smeenk, Hans de Boer, Tom Depuydt, Martina Kunze-Busch, Sofie Isebaert, Linda G.W. Kerkmeijer	25
20	Benefits of Elective Para-Aortic Radiotherapy for pN1 Prostate Cancer Using Arc Therapy (Intensity-Modulated or Volumetric Modulated Arc Therapy): Protocol for a Nonrandomized Phase II Trial 2018 ·JMIR Research Protocols ·Cédric Draulans, Steven Joniau, Valérie Fonteyne, Louke Delrue, Karel Decaestecker, Wouter Everaerts, Piet Dirix, Laura Van den Bergh, Wouter Crijns, (unknown), (unknown), Piet Ost, Nicolaas Lumen, (unknown), Karin Haustermans, Charlien Berghen, Gert De Meerleer	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact